LRMR Larimar Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$2,96
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$2,7252 haftanın en düşüğü
$6,4252 haftanın en yükseği
Piyasa Değeri (MRQ)
$307M
P/E
-1.7
Hisse Başına Kâr
$-1.32
rozetleriniz
52 Haftlık Aralık
$3–$6
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$14
P/E
-1.7
ROE
-167.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
LRMR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.96
Piyasa Değeri (MRQ)
$307M
P/E
-1.7
Hisse Başına Kâr
$-1.32
ROE
-167.4%
52 Haftlık Aralık
$3–$6
LRMR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Larimar Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar71
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2016-12-31 → 2019-12-31
Hisse Başına Kâr$-1.322020-12-31 → 2024-12-31
Serbest Nakit Akışı$-113M2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | LRMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -1.75Y ort. ≈-3.4 | ≈-3.4 | · | · | |
| F/D (MRQ) | 2.45Y ort. ≈2.5 | ≈2.5 | 1.9 | Aşırı değerli | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -2.25Y ort. ≈-4.6 | ≈-4.6 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -2.25Y ort. ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.15Y ort. ≈2.5 | ≈2.5 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | LRMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -95.8%5Y ort. ≈-54.6% | ≈-54.6% | -47.5% | Zayıf | |
| ROE | -167.4%5Y ort. ≈-71.7% | ≈-71.7% | -90.1% | Zayıf | |
| ROIC | -220.9%5Y ort. ≈-87.2% | ≈-87.2% | -56.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | LRMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 4.75Y ort. ≈7.8 | ≈7.8 | 5.2 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 1.35Y ort. ≈3.2 | ≈3.2 | 5.0 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-7.7%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.30 | $-0.39 | 22.8% |
| 31 Mart 2026 | May 14, 2026 | $-0.31 | $-0.55 | 43.2% |
| 31 Aralık 2025 | $-0.73 | $-0.52 | -41.2% | |
| 30 Eylül 2025 | $-0.61 | $-0.41 | -48.0% | |
| 30 Haziran 2025 | $-0.41 | $-0.49 | 16.3% | |
| 31 Mart 2025 | $-0.46 | $-0.43 | -7.8% | |
| 31 Aralık 2024 | $-0.45 | $-0.32 | -39.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $2.69 | $1.86 | $2.56 | $3.64 | $5.84 | $1.43 | $2.50 | $2.85 | $4.45 | · | $4.56 | |
| Cash Flow / Share | · | $-1.16 | $-0.76 | $-1.07 | $-2.45 | · | · | · | · | · | · | · | |
| Cash / Share | $1.03 | $0.52 | $0.61 | $0.62 | $3.96 | $4.43 | $0.73 | $1.32 | $1.48 | $1.18 | · | $2.54 | |
| EPS (TTM) | $-1.72 | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.23 | $1.52 | · | $1.62 | $1.87 | $2.25 | · | $3.11 | $3.31 | $3.62 | · | $2.11 | $2.31 | $2.46 | · | $2.74 | |
| Cash Flow / Share | · | · | · | · | · | $-0.41 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.89 | $1.71 | · | $1.05 | $0.32 | $0.33 | · | $0.55 | $0.51 | $1.73 | · | $0.88 | $2.18 | $2.58 | · | $1.99 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-1.14 | $-1.11 | $-0.96 | · | $-0.59 | $-0.75 | $-1.03 | · | $-1.81 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-173M | $-166M | · | $-132M | $-100M | $-95M | · | $-65M | $-58M | $-45M | · | $-33M | $-33M | $-33M | · | $-35M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | · | · | · | · | · | · | · | -5.7 | -6.5 | -7.9 | · | -6.7 | -4.2 | -4.4 | · | -1.8 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -17.4% | -15.3% | -12.7% | · | -14.9% | -24.0% | -22.7% | · | -56.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-166M | $-81M | $-37M | $-35M | $-51M |
| Seyreltilmiş Hisse Başı Kâr | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| Cari Oran | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-113M | $-71M | $-34M | $-28M | $-42M |
Kurumsal Sahipler (13F) 178 dosya · $309.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
178
Tutulan Değer
$309.2M
Yeni pozisyonlar
31
Çıkan pozisyonlar
29
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 31 (-21 önceki Ç'ye göre) | 29 (+15 önceki Ç'ye göre) | 70 (+12 önceki Ç'ye göre) | 44 (+3 önceki Ç'ye göre) | +7.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108.601.271 | 35.606.974 | 35,13% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $27.947.629 | 9.163.157 | 9,04% | Hisse senetleri |
| BlackRock, Inc. | $17.318.006 | 5.678.035 | 5,60% | Hisse senetleri |
| VANGUARD GROUP INC | $11.606.083 | 3.046.216 | 3,75% | Hisse senetleri |
| Defilade Capital Management, L.P. | $11.193.912 | 3.670.135 | 3,62% | Hisse senetleri |
| Driehaus Capital Management LLC | $9.648.440 | 3.163.423 | 3,12% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.073.448 | 2.974.901 | 2,93% | Hisse senetleri |
| RTW INVESTMENTS, LP | $7.826.297 | 2.565.999 | 2,53% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $7.232.813 | 2.371.414 | 2,34% | Hisse senetleri |
| MARSHALL WACE, LLP | $6.137.996 | 2.012.458 | 1,99% | Hisse senetleri |
| DAFNA Capital Management LLC | $6.124.900 | 2.008.164 | 1,98% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.346.375 | 1.752.910 | 1,73% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $5.121.921 | 1.679.003 | 1,66% | Hisse senetleri |
| Qube Research & Technologies Ltd | $5.005.178 | 1.641.042 | 1,62% | Hisse senetleri |
| CITADEL ADVISORS LLC | $4.443.316 | 1.456.825 | 1,44% | Hisse senetleri |
| STATE STREET CORP | $4.306.002 | 1.411.804 | 1,39% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.279.675 | 1.403.172 | 1,38% | Hisse senetleri |
| Woodline Partners LP | $4.272.593 | 1.400.850 | 1,38% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $4.065.763 | 1.333.037 | 1,32% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $2.932.299 | 961.083 | 0,95% | Hisse senetleri |
| FMR LLC | $2.858.971 | 937.368 | 0,92% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $2.824.312 | 926.004 | 0,91% | Hisse senetleri |
| Nuveen, LLC | $2.730.677 | 895.304 | 0,88% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $1.882.494 | 617.211 | 0,61% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.678.311 | 550.266 | 0,54% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.580.815 | 518.300 | 0,51% | Satım opsiyonu |
| VANGUARD FIDUCIARY TRUST CO | $1.366.912 | 448.168 | 0,44% | Hisse senetleri |
| Fi3 FINANCIAL ADVISORS, LLC | $1.263.896 | 2.915 | 0,41% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.218.604 | 399.542 | 0,39% | Hisse senetleri |
| SummitTX Capital, L.P. | $1.074.466 | 352.284 | 0,35% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.049.648 | 328.015 | 0,34% | Hisse senetleri |
| Gem Investment Advisors, LLC | $974.533 | 319.519 | 0,32% | Hisse senetleri |
| Burkehill Global Management, LP | $915.000 | 300.000 | 0,30% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $907.201 | 297.443 | 0,29% | Hisse senetleri |
| HAP Trading, LLC | $848.766 | 262.776 | 0,27% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $831.872 | 272.745 | 0,27% | Hisse senetleri |
| Cerity Partners LLC | $828.326 | 271.582 | 0,27% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821.975 | 269.500 | 0,27% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $732.610 | 240.200 | 0,24% | Satım opsiyonu |
| TWO SIGMA INVESTMENTS, LP | $720.206 | 236.133 | 0,23% | Hisse senetleri |
| Seven Fleet Capital Management LP | $704.309 | 230.921 | 0,23% | Hisse senetleri |
| HAP Trading, LLC | $687.173 | 237.776 | 0,22% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631.255 | 206.969 | 0,20% | Hisse senetleri |
| IEQ CAPITAL, LLC | $620.258 | 203.363 | 0,20% | Hisse senetleri |
| Caption Management, LLC | $588.705 | 193.018 | 0,19% | Hisse senetleri |
| Soleus Capital Management, L.P. | $573.711 | 188.102 | 0,19% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $523.775 | 162.159 | 0,17% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520.254 | 170.575 | 0,17% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $503.726 | 165.156 | 0,16% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $486.990 | 108.220 | 0,16% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 başvurular | 02 Mart 2026 | 34,41% | Değişiklik | Pasif yatırım | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 başvurular | 30 Haziran 2020 | · | İlk başvuru | · | SEC |
| Chondrial Therapeutics, Inc. | 27 Aralık 2019 | · | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 29 içeriden öğrenenler · 13 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 26 Ocak 2026 A | 368.276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 22 Ocak 2019 A | · | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 26 Ocak 2026 A | 215.785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 22 Ocak 2019 A | 19.793 | 0 | 0 | $0 |
| John B. Harlow Jr. | President and COO | 29 Eylül 2026 A | 50.000 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 28 Haziran 2018 S | 125.247 | 0 | 0 | $0 |
| Patrick Loustau | President | 31 Mart 2016 A | · | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 26 Ocak 2026 A | 76.443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 26 Ocak 2026 A | 71.443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 02 Nisan 2019 A | · | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 22 Ocak 2019 A | · | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 22 Ocak 2019 A | 21.443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 31 Mart 2016 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | Yönetim kurulu üyesi | 06 Temmuz 2026 P | 714.798 | 2 | 0 | $667.000 |
| Joseph Truitt | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 2.750 | 0 | 0 | $0 |
| Frank E Thomas | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 7.000 | 1 | 0 | $25.000 |
| Jeffrey W Sherman | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 5.000 | 1 | 0 | $25.000 |
| Jonathan S Leff | Yönetim kurulu üyesi | 19 Mayıs 2026 A | · | 0 | 0 | $0 |
| Peter Barrett | Yönetim kurulu üyesi | 10 Mayıs 2022 A | 4.643.327 | 0 | 0 | $0 |
| Thomas O Daniel | Yönetim kurulu üyesi | 12 Mayıs 2021 A | 19.452 | 0 | 0 | $0 |
| Wendy Everett | Yönetim kurulu üyesi | 26 Haziran 2019 A | · | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Yönetim kurulu üyesi | 26 Haziran 2019 A | 0 | 0 | 0 | $0 |
| Robert J Perez | Yönetim kurulu üyesi | 26 Haziran 2019 A | 5.322 | 0 | 0 | $0 |
| John L Lamattina | Yönetim kurulu üyesi | 26 Haziran 2019 A | 31.376 | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 03 Ocak 2018 A | 4.638.028 | 0 | 0 | $0 |
| Frances K Heller | Yönetim kurulu üyesi | 13 Ekim 2017 P | 47.961 | 0 | 0 | $0 |
| Kevin P Starr | Yönetim kurulu üyesi | 24 Eylül 2015 J | 370.323 | 0 | 0 | $0 |
| Avi Y. Goldberg | Yönetim kurulu üyesi | 18 Eylül 2015 S | 53.734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10% sahip | 26 Haziran 2020 J | 8 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 21 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,21% | 4.010 SH | 11 Eylül 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 92.953 SH | 02 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,06% | 225.822 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 7.348 SH | 02 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,02% | 625.151 SH | 11 Eylül 2026 | Günlük |
| IBB · iShares Trust | 0,01% | 394.961 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 382.844 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 71.780 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 340.789 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.693.182 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 31.780 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4.394 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 11.721 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 105.245 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.386 SH | 10 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,00% | 11.156 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 699.471 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.206.446 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.400 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 172.125 SH | 19 Ağustos 2026 | Günlük |
LRMR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 17 analist
AL
Medyan hedef
$13.00
+339,2%
8 47,1%
Güçlü Al
8 47,1%
Al
1 5,9%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
10 analist · 2026-09-29Ortalama hedef $14.40 +386,5%
← Tüm hedeflerin altında
Mevcut fiyat $2.96
Düşük$5.00
Ortalama$14.40
Yüksek$26.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| SCTX | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026